1. Complex: BAFF (CD257) in complex with belimumab
Resolution: 2 Å
Species: H. sapiens
2. Antigen: B-cell activating factor, BAFF, CD257, tumor necrosis factor ligand superfamily member 13B, TNFSF13B
structure length (residues): 152
mutations: No
3. Antibody: belimumab
Isotype/subclass: IgG1λ
Structure: Fab only.
3.1 Heavy chain
structure length (residues): 235
mutations: No
disulfide bridges: 22-96, 150-206
CDR (residue numbering): 31, 54, 55, 57, 101-104
3.2 Light chain
structure length (residues): 214
mutations: No
disulfide bridges: 22-87, 136-195
CDR (residue numbering): 28, 31, 50, 95
RCSB PDB - 5Y9J: BAFF in complex with belimumab
BAFF in complex with belimumab (310K, 37°C, 100 ns) >> RMSD, SASA, RMSF, Rg, H-bonds
BAFF in complex with belimumab (311K, 38°C, 100 ns) >> RMSD, SASA, RMSF, Rg, H-bonds
BAFF in complex with belimumab (312K, 39°C, 100 ns) >> RMSD, SASA, RMSF, Rg, H-bonds
BAFF in complex with belimumab (313K, 40°C, 100 ns) >> RMSD, SASA, RMSF, Rg, H-bonds
1. Complex: BAFF (CD257, oligomerized) in complex with belimumab
Resolution: 2.9 Å
Species: H. sapiens
2. Antigen: B-cell activating factor, BAFF, CD257, tumor necrosis factor ligand superfamily member 13B, TNFSF13B
structure length (residues): 164
mutations: 1
3. Antibody: belimumab
Isotype/subclass: IgG1λ
Structure: Fab only
3.1 Heavy chain
structure length (residues): 225
mutations: No
disulfide bridges: 22-96, 150-206
CDR (residue numbering): 31, 54, 55, 57, 59, 101-104
3.2 Light chain
structure length (residues): 214
mutations: No
disulfide bridges: 22-87, 136-195
CDR (residue numbering): 27-31, 50, 65, 66, 94, 95
RCSB PDB - 6FXN: Human BAFF in complex with belimumab